TipRanks
Go Ultimate55% OFF

MEMSCAP SA (MEMS) AI Stock Analysis

FR:MEMS

MEMSCAP SA

(Paris:MEMS)

Select Model
Rating:60Neutral
Price Target:EUR 5.50â–²(13.87% Upside)
Action:reiterated
Date:10/28/26

The overall score of 60 reflects a company with a fundamentally sound financial position, weighed down by weak technical momentum and a high valuation. The strong balance sheet and cash flow generation are the primary strengths, but the stock is currently out of favor in the market, trading below key moving averages with bearish momentum indicators. The high P/E ratio adds a layer of risk, as the market is pricing in growth that the recent income statement does not fully support.

Positive Factors
Sustained ProfitabilityReturning to positive net income from 2022 through 2025 shows that MEMSCAP’s business model has regained earnings capacity after earlier losses. Continued profitability provides internal funding for operations and investment, while creating a more stable base for managing cyclical demand across its served markets.
Negative Factors
Declining RevenueRevenue contraction after the 2023 peak signals weaker demand or reduced business momentum across MEMSCAP’s markets. If the decline persists, lower scale can constrain operating leverage, reduce resources available for development, and make it harder to sustain the company’s recent profitability.

MEMSCAP SA (MEMS) vs. iShares MSCI France ETF (EWQ)

-10%0%10%20%30%40%50%60%70%FR:MEMS+26.60%EWQ-0.37%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
EUR 38.13M
Dividend Yield
1.33%
Average Volume (3M)
9,865
Price to Earnings (P/E)
35.1
Beta (1Y)
0.98
Revenue Growth
10.87%
EPS Growth
46.41%
Country
France
Employees
55
Sector
Technology
Sector Strength
61
Industry
Semiconductors

MEMSCAP SA Business Overview & Revenue Model

Company Description

Memscap, S.A. is a Crolles, France-based company, founded in 1997, that develops and delivers advanced micro-electro-mechanical systems (MEMS) solutions. Catering to a global clientele, the company serves diverse sectors including aerospace and defen...

MEMSCAP SA Financial Statement Overview

Summary

The company's financial health is solid, anchored by a strong balance sheet (Score: 85) and consistent cash generation (Score: 78). While the income statement shows moderate growth and some margin pressure (Score: 64), the low leverage and positive free cash flow provide a stable foundation.

Income Statement

64Positive

Balance Sheet

85Very Positive

Cash Flow

78Positive
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue12.78M11.99M12.66M14.07M9.34M8.54M
Gross Profit5.13M4.96M5.02M6.04M3.68M3.63M
EBITDA1.42M1.43M2.36M3.04M1.45M1.63M
Net Income1.09M894.00K1.37M2.14M1.05M-328.00K
Balance Sheet
Total Assets26.77M25.37M25.83M26.28M23.45M25.43M
Cash, Cash Equivalents and Short-Term Investments4.23M4.46M3.96M4.80M4.18M3.92M
Total Debt4.97M4.48M5.04M5.71M5.28M6.18M
Total Liabilities7.37M6.33M7.56M8.61M7.86M9.65M
Stockholders Equity19.40M19.04M18.27M17.68M15.59M15.79M
Cash Flow
Free Cash Flow1.30M1.26M342.00K1.41M-161.00K1.57M
Operating Cash Flow1.40M1.36M548.00K1.75M100.00K1.59M
Investing Cash Flow-26.00K-196.00K-192.00K-491.00K1.35M-192.00K
Financing Cash Flow-1.16M-665.00K-1.19M-593.00K-706.00K-738.00K

MEMSCAP SA Technical Analysis

Technical Analysis SentimentPositive
Last Price4.83

Price Trends

50DMA4.93Positive
100DMA4.93Positive
200DMA4.88Positive

Market Momentum

MACD-0.01Negative
RSI54.39Neutral
STOCH82.71Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:MEMS, the sentiment is Positive. The current price of 4.83 is above the 20-day moving average (MA) of 4.78, below the 50-day MA of 4.93, and below the 200-day MA of 4.88, indicating a bullish trend. The MACD of -0.01 indicates Negative momentum. The RSI at 54.39 is Neutral, neither overbought nor oversold. The STOCH value of 82.71 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FR:MEMS.

MEMSCAP SA Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

FR:MEMS against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *61Neutral$37.18B12.37-10.20%1.83%8.50%-7.62%
FR:MEMSFR:MEMS60NeutralEUR 38.13M35.145.66%1.33%10.87%46.41%

* Technology Sector Average

Performance Comparison

0%20%40%60%FR:MEMSDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
FR:MEMS and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
FR:MEMSMEMSCAP SA4.961.1028.37%

MEMSCAP SA Corporate Events

MEMSCAP triples operating income on broad‑based Q3 growth

Oct 26, 2026

MEMSCAP reported a strong third quarter of 2026, with revenue up 27.1% year on year to €3.33 million and nine‑month sales rising 17.2% to €10.27 million, driven by broad‑based growth in aeronautics, medical and optical communi...

MEMSCAP Schedules Investor Call on Q3 2026 Results

Oct 20, 2026

MEMSCAP will host a videoconference on October 27 to discuss its third-quarter 2026 results, which are scheduled for publication after market close on October 26. Chairman and CEO Jean Michel Karam will answer questions from shareholders and investor...

MEMSCAP Cancels Treasury Shares as It Deepens Shareholder-Return Strategy

Sep 8, 2026

MEMSCAP’s board has approved a 1.37% reduction in its share capital through the cancellation of 105,483 treasury shares acquired under a 2024 buyback program, cutting nominal capital from 1,926,725.50 euros to 1,900,354.75 euros and leaving 7,6...

MEMSCAP lifts first-half profit 53% and pays inaugural dividend

Aug 31, 2026

MEMSCAP reported a 13% rise in first-half 2026 revenue to 6.94 million euros, driven by broad-based growth across aeronautics, medical and optical communications. Aeronautics remained the main business at 69% of sales, while medical revenue surged 56...

MEMSCAP to Host Investor Webcast on First‑Half 2026 Results

Aug 26, 2026

MEMSCAP SA will publish its first‑half 2026 financial results after market close on Monday, August 31, 2026, and follow up with a video conference for shareholders and investors on Tuesday, September 1 at 10:00 a.m. The session will be led by C...

MEMSCAP lifts revenue and margins on aerospace and medical demand

Jul 28, 2026

MEMSCAP reported second-quarter 2026 revenue of €3.64 million, up 19.9% year on year, with aerospace remaining the main growth engine at 71% of sales and medical revenue surging 78.8% on strong demand for invasive blood pressure monitoring. Opt...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 28, 2026